These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11186327)

  • 1. Therapeutic angiogenesis: a case for targeted, regulated gene delivery.
    Webster KA
    Crit Rev Eukaryot Gene Expr; 2000; 10(2):113-25. PubMed ID: 11186327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic angiogenesis: a complex problem requiring a sophisticated approach.
    Webster KA
    Cardiovasc Toxicol; 2003; 3(3):283-98. PubMed ID: 14555793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.
    Khan TA; Sellke FW; Laham RJ
    Gene Ther; 2003 Feb; 10(4):285-91. PubMed ID: 12595887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis for the treatment of vascular diseases.
    Chawla PS; Keelan MH; Kipshidze N
    Int Angiol; 1999 Sep; 18(3):185-92. PubMed ID: 10688416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy of the ischemic lower limb--Therapeutic angiogenesis.
    Bobek V; Taltynov O; Pinterova D; Kolostova K
    Vascul Pharmacol; 2006 Jun; 44(6):395-405. PubMed ID: 16698324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis and gene therapy in man: dream or reality?
    Amant C; Berthou L; Walsh K
    Drugs; 1999; 59 Spec No():33-6. PubMed ID: 10548390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
    Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic angiogenesis as a new experimental treatment for vascular disease].
    Lucassen AM; de Waal RM; Verheugt FW
    Ned Tijdschr Geneeskd; 2000 Apr; 144(14):650-5. PubMed ID: 10774292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?
    Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ
    Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis therapy in ischemic disease.
    Silvestre JS; Lévy BI
    Arch Mal Coeur Vaiss; 2002 Mar; 95(3):189-96. PubMed ID: 11998334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical and clinical experience in vascular gene therapy: advantages over conservative/standard therapy.
    Nikol S; Huehns TY
    J Invasive Cardiol; 2001 Apr; 13(4):333-8. PubMed ID: 11287726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.
    Vajanto I; Rissanen TT; Rutanen J; Hiltunen MO; Tuomisto TT; Arve K; Närvänen O; Manninen H; Räsänen H; Hippeläinen M; Alhava E; Ylä-Herttuala S
    J Gene Med; 2002; 4(4):371-80. PubMed ID: 12124979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factors for therapeutic angiogenesis in peripheral arterial disease.
    Jones WS; Annex BH
    Curr Opin Cardiol; 2007 Sep; 22(5):458-63. PubMed ID: 17762548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia.
    Rinsch C; Quinodoz P; Pittet B; Alizadeh N; Baetens D; Montandon D; Aebischer P; Pepper MS
    Gene Ther; 2001 Apr; 8(7):523-33. PubMed ID: 11319619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic angiogenesis for myocardial ischemia.
    Rosinberg A; Khan TA; Sellke FW; Laham RJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):271-83. PubMed ID: 15151475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.
    Qian HS; Liu P; Huw LY; Orme A; Halks-Miller M; Hill SM; Jin F; Kretschmer P; Blasko E; Cashion L; Szymanski P; Vergona R; Harkins R; Yu J; Sessa WC; Dole WP; Rubanyi GM; Kauser K
    Gene Ther; 2006 Sep; 13(18):1342-50. PubMed ID: 16642030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?
    Francis SC; Raizada MK; Mangi AA; Melo LG; Dzau VJ; Vale PR; Isner JM; Losordo DW; Chao J; Katovich MJ; Berecek KH
    Physiol Genomics; 2001 Dec; 7(2):79-94. PubMed ID: 11773594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
    Rajagopalan S; Mohler ER; Lederman RJ; Mendelsohn FO; Saucedo JF; Goldman CK; Blebea J; Macko J; Kessler PD; Rasmussen HS; Annex BH
    Circulation; 2003 Oct; 108(16):1933-8. PubMed ID: 14504183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction--an obstacle of therapeutic angiogenesis.
    Sun L; Bai Y; Du G
    Ageing Res Rev; 2009 Oct; 8(4):306-13. PubMed ID: 19389489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular endothelial growth factor and its application in therapy of cardiovascular diseases].
    Kowalczyk J; Pasyk S
    Pol Merkur Lekarski; 2002 Jul; 13(73):74-8. PubMed ID: 12362514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.